20160107 Strategic update ENG clean
Category: 2016
Transgene Announces First Patient Randomized in Multinational Phase 3 Trial for Pexa-Vec Oncolytic Immunotherapy in Advanced Liver Cancer
20160106 Ph 3 pexa vec in HCC trial initiation VER8
20160107 Strategic update ENG clean
20160106 Ph 3 pexa vec in HCC trial initiation VER8